A chemiluminescent-western blot assay for quantitative detection of Plasmodium falciparum circumsporozoite protein

Journal of Immunological Methods

Volumn 390, Issue 1-2, 2013, Pages 99-105

  Kumar, Sanjai ^a   Zheng, Hong ^a   Sangweme, Davison T ^b   Mahajan, Babita ^a   Kozakai, Yukiko ^a   Pham, Phuong T ^a   Morin, Merribeth J ^c   Locke, Emily ^c   Kumar, Nirbhay ^b  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c PATH Malaria Vaccine Initiative   (United States)

Author keywords

Chemiluminescent western blot; Circumsporozoite protein; IOD; Plasmodium falciparum

Indexed keywords

CIRCUMSPOROZOITE PROTEIN; MALARIA VACCINE; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; HUMAN; HUMAN CELL; IMMUNODETECTION; MALARIA; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; SALIVARY GLAND; SPOROZOITE; WESTERN BLOTTING;

ALGORITHMS; BLOTTING, WESTERN; HUMANS; KINETICS; LUMINESCENT MEASUREMENTS; MALARIA VACCINES; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; RECOMBINANT PROTEINS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPOROZOITES;

PLASMODIUM FALCIPARUM;

EID: 84875233699     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2013.02.001     Document Type: Article

References (23)

1. Agnandji S.T., Lell B., Soulanoudjingar S.S., Fernandes J.F., Abossolo B.P., Conzelmann C., Methogo B.G., Doucka Y., Flamen A., Mordmuller B., Issifou S., Kremsner P.G., Sacarlal J., Aide P., Lanaspa M., Aponte J.J., Nhamuave A., Quelhas D., Bassat Q., Mandjate S., Macete E., Alonso P., Abdulla S., Salim N., Juma O., Shomari M., Shubis K., Machera F., Hamad A.S., Minja R., Mtoro A., Sykes A., Ahmed S., Urassa A.M., Ali A.M., Mwangoka G., Tanner M., Tinto H., D'Alessandro U., Sorgho H., Valea I., Tahita M.C., Kabore W., Ouedraogo S., Sandrine Y., Guiguemde R.T., Ouedraogo J.B., Hamel M.J., Kariuki S., Odero C., Oneko M., Otieno K., Awino N., Omoto J., Williamson J., Muturi-Kioi V., Laserson K.F., Slutsker L., Otieno W., Otieno L., Nekoye O., Gondi S., Otieno A., Ogutu B., Wasuna R., Owira V., Jones D., Onyango A.A., Njuguna P., Chilengi R., Akoo P., Kerubo C., Gitaka J., Maingi C., Lang T., Olotu A., Tsofa B., Bejon P., Peshu N., Marsh K., Owusu-Agyei S., Asante K.P., Osei-Kwakye K., Boahen O., Ayamba S., Kayan K., Owusu-Ofori R., Dosoo D., Asante I., Adjei G., Chandramohan D., Greenwood B., Lusingu J., Gesase S., Malabeja A., Abdul O., Kilavo H., Mahende C., Liheluka E., Lemnge M., et al. First results of phase 3 trial of RTS, S/AS01 malaria vaccine in African children. N. Engl. J. Med. 2011, 365:1863.
2. Ballou W.R., Rothbard J., Wirtz R.A., Gordon D.M., Williams J.S., Gore R.W., Schneider I., Hollingdale M.R., Beaudoin R.L., Maloy W.L., et al. Immunogenicity of synthetic peptides from circumsporozoite protein of Plasmodium falciparum. Science 1985, 228:996.
3. Burkot T.R., Da Z.W., Geysen H.M., Wirtz R.A., Saul A. Fine specificities of monoclonal antibodies against the Plasmodium falciparum circumsporozoite protein: recognition of both repetitive and non-repetitive regions. Parasite Immunol. 1991, 13:161.
4. Contreras-Rodriguez A., Quiroz-Limon J., Martins A.M., Peralta H., Avila-Calderon E., Sriranganathan N., Boyle S.M., Lopez-Merino A. Enzymatic, immunological and phylogenetic characterization of Brucella suis urease. BMC Microbiol. 2008, 8:121.
5. Egan J.E., Weber J.L., Ballou W.R., Hollingdale M.R., Majarian W.R., Gordon D.M., Maloy W.L., Hoffman S.L., Wirtz R.A., Schneider I., et al. Efficacy of murine malaria sporozoite vaccines: implications for human vaccine development. Science 1987, 236:453.
6. Heidebrecht F., Heidebrecht A., Schulz I., Behrens S.E., Bader A. Improved semiquantitative Western blot technique with increased quantification range. J. Immunol. Methods 2009, 345:40.
7. Hill A.V. Pre-erythrocytic malaria vaccines: towards greater efficacy. Nat. Rev. Immunol. 2006, 6:21.
8. Hollingdale M.R., Nardin E.H., Tharavanij S., Schwartz A.L., Nussenzweig R.S. Inhibition of entry of Plasmodium falciparum and P. vivax sporozoites into cultured cells; an in vitro assay of protective antibodies. J. Immunol. 1984, 132:909.
9. McCutchan T.F., Kissinger J.C., Touray M.G., Rogers M.J., Li J., Sullivan M., Braga E.M., Krettli A.U., Miller L.H. Comparison of circumsporozoite proteins from avian and mammalian malarias: biological and phylogenetic implications. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:11889.
10. Michaelis L., Menten M.L. Kinetics of invertase action. Biochem. Z. 1913, 49:333.
11. Mlambo G., Kumar N., Yoshida S. Functional immunogenicity of baculovirus expressing Pfs25, a human malaria transmission-blocking vaccine candidate antigen. Vaccine 2010, 28:7025.
12. Nardin E.H., Nussenzweig V., Nussenzweig R.S., Collins W.E., Harinasuta K.T., Tapchaisri P., Chomcharn Y. Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax. J. Exp. Med. 1982, 156:20.
13. Pacheco N.D., Strome C.P., Mitchell F., Bawden M.P., Beaudoin R.L. Rapid, large-scale isolation of Plasmodium berghei sporozoites from infected mosquitoes. J. Parasitol. 1979, 65:414.
14. Potocnjak P., Yoshida N., Nussenzweig R.S., Nussenzweig V. Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection. J. Exp. Med. 1980, 151:1504.
15. Rich S.M., Ayala F.J. Population structure and recent evolution of Plasmodium falciparum. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:6994.
16. Weber J.L., Hockmeyer W.T. Structure of the circumsporozoite protein gene in 18 strains of Plasmodium falciparum. Mol. Biochem. Parasitol. 1985, 15:305.
17. Wirtz R.A., Zavala F., Charoenvit Y., Campbell G.H., Burkot T.R., Schneider I., Esser K.M., Beaudoin R.L., Andre R.G. Comparative testing of monoclonal antibodies against Plasmodium falciparum sporozoites for ELISA development. Bull. World Health Organ. 1987, 65:39.
18. Young J.F., Hockmeyer W.T., Gross M., Ballou W.R., Wirtz R.A., Trosper J.H., Beaudoin R.L., Hollingdale M.R., Miller L.H., Diggs C.L., et al. Expression of Plasmodium falciparum circumsporozoite proteins in Escherichia coli for potential use in a human malaria vaccine. Science 1985, 228:958.
19. Zavala F., Cochrane A.H., Nardin E.H., Nussenzweig R.S., Nussenzweig V. Circumsporozoite proteins of malaria parasites contain a single immunodominant region with two or more identical epitopes. J. Exp. Med. 1983, 157:1947.
20. Zavala F., Masuda A., Graves P.M., Nussenzweig V., Nussenzweig R.S. Ubiquity of the repetitive epitope of the CS protein in different isolates of human malaria parasites. J. Immunol. 1985, 135:2790.
21. Zavala F., Tam J.P., Hollingdale M.R., Cochrane A.H., Quakyi I., Nussenzweig R.S., Nussenzweig V. Rationale for development of a synthetic vaccine against Plasmodium falciparum malaria. Science 1985, 228:1436.
22. Zeeshan M., Alam M.T., Vinayak S., Bora H., Tyagi R.K., Alam M.S., Choudhary V., Mittra P., Lumb V., Bharti P.K., Udhayakumar V., Singh N., Jain V., Singh P.P., Sharma Y.D. Genetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS, S malaria vaccine. PLoS One 2012, 7:e43430.
23. Zhivkov P., Waniewski J. Modelling tumour-immunity interactions with different simulation functions. Int. J. Appl. Math. Comput. Sci. 2003, 13:307.